chr1-167435434-G-A
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_198053.3(CD247):c.301C>T(p.Gln101*) variant causes a stop gained, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000272 in 1,611,206 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a pathogenic outcome for this variant. 2/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_198053.3 stop_gained, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000204 AC: 31AN: 152184Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000263 AC: 66AN: 250742Hom.: 1 AF XY: 0.000251 AC XY: 34AN XY: 135496
GnomAD4 exome AF: 0.000280 AC: 408AN: 1459022Hom.: 1 Cov.: 29 AF XY: 0.000289 AC XY: 210AN XY: 726076
GnomAD4 genome AF: 0.000204 AC: 31AN: 152184Hom.: 0 Cov.: 32 AF XY: 0.000215 AC XY: 16AN XY: 74332
ClinVar
Submissions by phenotype
Immunodeficiency 25 Pathogenic:2
Likely pathogenic, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Oct 31, 2018 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 28, 2023 | This sequence change creates a premature translational stop signal (p.Gln101*) in the CD247 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CD247 are known to be pathogenic (PMID: 17170122, 26542031). This variant is present in population databases (rs55729925, gnomAD 0.07%). This variant has not been reported in the literature in individuals affected with CD247-related conditions. ClinVar contains an entry for this variant (Variation ID: 419227). For these reasons, this variant has been classified as Pathogenic. - |
CD247-related disorder Pathogenic:1
Likely pathogenic, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Aug 22, 2024 | The CD247 c.301C>T variant is predicted to result in premature protein termination (p.Gln101*). This variant was reported in the heterozygous state, and interpreted as pathogenic, in individuals undergoing preconception carrier screening analyses (Supplementary Table 001, Capalbo et al. 2019. PubMed ID: 31589614). This variant is reported in 0.068% of alleles in individuals of European (Finnish) descent in gnomAD. Nonsense variants in CD247 are expected to be pathogenic. This variant is interpreted as likely pathogenic. - |
Severe combined immunodeficiency disease Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Apr 30, 2024 | Variant summary: CD247 c.301C>T (p.Gln101X) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. The variant allele was found at a frequency of 0.00026 in 250742 control chromosomes in the gnomAD database, including 1 homozygotes. This frequency is not significantly higher than estimated for a pathogenic variant in CD247 causing Severe Combined Immunodeficiency (0.00026 vs 0.00035), allowing no conclusion about variant significance. c.301C>T has been reported in the literature in individuals affected with Primary immunodeficiencies (examples: Gallo_2016 and Rudilla_2019). The following publications have been ascertained in the context of this evaluation (PMID: 27872624, 31681265). ClinVar contains an entry for this variant (Variation ID: 419227). Based on the evidence outlined above, the variant was classified as pathogenic. - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Jun 23, 2015 | The Q101X nonsense variant in the CD3Z gene is predicted to cause loss of normal protein function either through protein truncation or nonsense-mediated mRNA decay. The Q101X variant was not observed at any significant frequency in approximately 8,600 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project. Therefore, we consider this variant to be pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at